Keywords: AMI; Acute myocardial infarction; C1-inh; C1-inhibitor; C1s-inh; C1s-inhibitor; C4BP; C4b-binding protein; CK(-MB); creatine kinase (-MB); CPN; carboxypeptidase-N; CR1; complement receptor 1; CVF; cobra venom factor; DDA; disodium disuccinate astaxanthin;